Darolutamide
Bayer
['crpc', 'pcsm', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'darolutamide']
darolutamide demonstrates favorable tolerability, decreased metastatic progression in nmcrpc #pcsm #gu23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.